In the present study we investigated the expression of two ICP inhibitors, PD1 and TIM3 on BM T lymphocytes and their ligands PDL1 and Gal9 on blast cells and LSCs in 85 newly diagnosed ALL patients. This evidence concerns the gene HAVCR2 and acute lymphoblastic leukemia.